Filter Results
:
(61)
Show Results For
-
All HBS Web
(1,139)
- Faculty Publications (61)
Show Results For
-
All HBS Web
(1,139)
- Faculty Publications (61)
- December 2018
- Case
Corporate Transformation at Merck KGaA, Darmstadt, Germany
By: Joseph B. Fuller, Amy C. Edmondson, Daniela Beyersdorfer and Tonia Labruyere
When Stefan Oschmann became CEO and chairman of the executive board of Merck KGaA, Darmstadt, Germany, in 2016, the company had started its transformation from a mid-tier traditional German industry player to a global modern science and technology player. The...
View Details
Keywords:
Corporate Governance With Family Ownership;
Transformation;
Change Management;
Restructuring;
Corporate Governance;
Family Ownership
Fuller, Joseph B., Amy C. Edmondson, Daniela Beyersdorfer, and Tonia Labruyere. "Corporate Transformation at Merck KGaA, Darmstadt, Germany." Harvard Business School Case 319-072, December 2018.
- September 2018
- Case
Verisk: Trailblazing in the Big Data Jungle
By: Andrew Wasynczuk, Francesca Gino and Karim Sameh
This case revolves around Verisk Analytics' initiatives to drive innovation throughout the firm's many business verticals. Verisk, originally named ISO, started life as an insurance rating agency in the early 1970s, acting as an intermediary between insurance companies...
View Details
Keywords:
Verisk;
Argus;
Wood Mackenzie;
Insurance;
Energy;
Analytics;
Data;
Big Data;
Acquisitions;
Acquisition Strategy;
Innovation;
Organic Growth;
Innovation Strategy;
Innovation Leadership;
Technological Innovation;
Acquisition;
Growth and Development Strategy;
Analytics and Data Science;
Insurance Industry;
Energy Industry;
Consulting Industry;
United States;
United Kingdom;
New York (state, US);
England
Wasynczuk, Andrew, Francesca Gino, and Karim Sameh. "Verisk: Trailblazing in the Big Data Jungle." Harvard Business School Case 919-014, September 2018.
- April 2018
- Supplement
Celgene
By: Malcolm Baker and Emily R. McComb
In February 2011, Adam Koppel, a Managing Director at Brookside Capital, the public equity arm of Bain Capital, must decide whether to increase or exit the firm’s position in Celgene Corporation. News has emerged that raises potential safety concerns associated with...
View Details
- March 2018 (Revised May 2018)
- Case
Celgene
By: Malcolm Baker and Emily McComb
In February 2011, Adam Koppel, a managing director at Brookside Capital, the public equity arm of Bain Capital, must decide whether to increase or exit the firm’s position in Celgene Corporation. News has emerged that raises potential safety concerns associated with...
View Details
Keywords:
Life Sciences;
Biotechnology;
Public Market Investing;
Celgene;
Revlimid;
Hedge Fund;
Growth Stocks;
Valuation;
Investment;
Decision Choices and Conditions;
Analysis;
Biotechnology Industry
Baker, Malcolm, and Emily McComb. "Celgene." Harvard Business School Case 218-094, March 2018. (Revised May 2018.)
- March 2018 (Revised May 2018)
- Supplement
Celgene (B)
By: Malcolm Baker and Emily McComb
Supplements the (A) case.
View Details
Keywords:
Life Sciences;
Biotechnology;
Public Market Investing;
Celgene;
Revlimid;
Hedge Fund;
Growth Stocks;
Valuation;
Investment;
Decision Choices and Conditions;
Analysis;
Biotechnology Industry
Baker, Malcolm, and Emily McComb. "Celgene (B)." Harvard Business School Supplement 218-099, March 2018. (Revised May 2018.)
- January 2018
- Article
Big Data and Big Cities: The Promises and Limitations of Improved Measures of Urban Life
By: Edward L. Glaeser, Scott Duke Kominers, Michael Luca and Nikhil Naik
New, "big" data sources allow measurement of city characteristics and outcome variables at higher frequencies and finer geographic scales than ever before. However, big data will not solve large urban social science questions on its own. Big data has the most value for...
View Details
Glaeser, Edward L., Scott Duke Kominers, Michael Luca, and Nikhil Naik. "Big Data and Big Cities: The Promises and Limitations of Improved Measures of Urban Life." Economic Inquiry 56, no. 1 (January 2018): 114–137.
- May 2017
- Teaching Plan
Neurotrack and the Alzheimer's Puzzle
By: Richard G. Hamermesh and Carin-Isabel Knoop
Teaching Note for HBS No. 816-072.
View Details
- November 2016
- Case
QuintilesIMS: Biosimilar Marketing in England
By: John A. Quelch and Emily C. Boudreau
QuintilesIMS was a leading healthcare consulting firm best known for its data and information offerings as well as its market research and management consulting services for life science companies. By 2015, the company was expanding beyond the biopharmaceutical...
View Details
Keywords:
Health;
Pharmaceutical Industry;
Biotech;
Marketing;
Health Care and Treatment;
Biotechnology Industry;
England
Quelch, John A., and Emily C. Boudreau. "QuintilesIMS: Biosimilar Marketing in England." Harvard Business School Case 517-054, November 2016.
- November 2016 (Revised April 2017)
- Case
Basecamp: Pricing
By: Frank Cespedes and Robb Fitzsimmons
A data analyst at Basecamp is evaluating the results of pricing research and its potential implications for the venture’s latest version of its project management software product.
View Details
Keywords:
Pricing;
Entrepreneurial Management;
Data Analysis;
Marketing;
Customer Acquisition;
Customer Retention;
Value Proposition;
Sales Management;
Product Management;
Market Research;
Life Time Value;
Testing;
Entrepreneurship;
Analytics and Data Science;
Customers;
Value;
Sales;
Product Marketing;
United States
Cespedes, Frank, and Robb Fitzsimmons. "Basecamp: Pricing." Harvard Business School Case 817-067, November 2016. (Revised April 2017.)
- 2016
- Book
Antonio Serra and the Economics of Good Government
By: Rosario Patalano and Sophus A. Reinert
Little is known of Antonio Serra except that he wrote his extraordinary 1613 Short Treatise on the Causes That Make Kingdoms Abound in Gold and Silver even in the Absence of Mines in a Neapolitan jail and that he died there soon afterwards. However, the...
View Details
Patalano, Rosario and Sophus A. Reinert, eds. Antonio Serra and the Economics of Good Government. Palgrave Studies in the History of Finance. New York: Palgrave Macmillan, 2016.
- Article
What to Know About Locating in a Cluster
By: Willy C. Shih and Sen Chai
As a study of two industry clusters in Denmark shows, factors that can make clusters attractive—easy people movement and knowledge spillovers—can also make it harder for individual companies to retain proprietary knowledge.
View Details
Keywords:
Clusters;
Clustering;
Competitiveness;
Life Sciences;
Telecommunications;
Science-based;
Research And Development;
Industry Clusters;
Research;
Innovation Strategy;
Innovation and Management;
Geographic Location;
Pharmaceutical Industry;
Biotechnology Industry;
Telecommunications Industry;
Food and Beverage Industry;
Denmark
Shih, Willy C., and Sen Chai. "What to Know About Locating in a Cluster." Art. 57117. MIT Sloan Management Review 57, no. 1 (Fall 2015): 104–107.
- March 2015 (Revised February 2017)
- Case
Shanghai: GDP Apostasy
By: George Serafeim
Balancing economic growth alongside environmental sustainability and social inclusion was becoming increasingly important in China. The case describes Shanghai's decision to abandon growth of Gross Domestic Product (GDP) as its primary metric of measuring success....
View Details
Keywords:
China;
Gdp;
Measurement;
Measurement Problems;
Accountability;
Sustainability;
Sustainable Development;
Strategy Execution;
Strategy;
Balanced Scorecard;
Strategy Map;
Macroeconomics;
Measurement and Metrics;
Corporate Accountability;
Accounting;
Environmental Sustainability;
Development Economics;
Corporate Governance;
Shanghai
Serafeim, George, Rebecca Henderson, and David Freiberg. "Shanghai: GDP Apostasy." Harvard Business School Case 115-042, March 2015. (Revised February 2017.)
- July 2014 (Revised January 2017)
- Course Overview Note
Building Life Science Businesses Spring Term 2017: Course Outline and Syllabus
This Course Outline and Syllabus gives an overview of the Spring 2016 class Building Life Science Businesses.7
View Details
Keywords:
Healthcare Ventures;
Entrepreneurial Management;
Entrepreneurship;
Entrepreneurs;
Health Care and Treatment;
Health Testing and Trials;
Medical Specialties;
Health Industry;
Biotechnology Industry;
Medical Devices and Supplies Industry;
Asia;
North America;
Europe
Hamermesh, Richard G. "Building Life Science Businesses Spring Term 2017: Course Outline and Syllabus." Harvard Business School Course Overview Note 815-003, July 2014. (Revised January 2017.)
- May 2014 (Revised November 2014)
- Case
Houston We Have A Problem: NASA and Open Innovation (A)
By: Michael Tushman, Hila Lifshitz-Assaf and Kerry Herman
Jeff Davis, director of Space Life Sciences Directorate (SLSD) at NASA, has been working for several years to raise awareness amongst scientists and researchers in his organizations of the benefits of open innovation as a successful and efficient way to collaborate on...
View Details
Tushman, Michael, Hila Lifshitz-Assaf, and Kerry Herman. "Houston We Have A Problem: NASA and Open Innovation (A)." Harvard Business School Case 414-044, May 2014. (Revised November 2014.)
- May 2014 (Revised November 2014)
- Supplement
Houston We Have A Solution: NASA and Open Innovation (B)
By: Michael Tushman, Hila Lifshitz-Assaf and Kerry Herman
Jeff Davis, director of Space Life Sciences Directorate at NASA, has been working for several years to raise awareness amongst scientists and researchers in his organizations of the benefits of open innovation as a successful and efficient way to collaborate on...
View Details
Tushman, Michael, Hila Lifshitz-Assaf, and Kerry Herman. "Houston We Have A Solution: NASA and Open Innovation (B)." Harvard Business School Supplement 414-057, May 2014. (Revised November 2014.)
- 2014
- Working Paper
The Organizational and Geographic Drivers of Absorptive Capacity: An Empirical Analysis of Pharmaceutical R&D Laboratories
By: Francesca Lazzeri and Gary P. Pisano
Scholars and practitioners alike now recognize that a firm's capacity to assimilate and use know-how from external sources—what Cohen and Levinthal (1990) called "absorptive capacity"—plays a central role in innovation performance. In recent years, a common strategy...
View Details
Keywords:
Geographic Location;
Industry Clusters;
Knowledge Acquisition;
Pharmaceutical Industry;
San Francisco;
San Diego;
Massachusetts
Lazzeri, Francesca, and Gary P. Pisano. "The Organizational and Geographic Drivers of Absorptive Capacity: An Empirical Analysis of Pharmaceutical R&D Laboratories." Harvard Business School Working Paper, No. 14-098, April 2014.
- February 2014
- Case
BGI: Data-driven Research
By: Willy Shih and Sen Chai
BGI has the largest installed gene-sequencing capacity in the world, and to Zhang Gengyun, general manager of the Life Sciences Division, this represented an opportunity to apply his training as a plant breeder and his early career work as a biochemist to improving...
View Details
Keywords:
Genomics;
Gene Sequencing;
Life Sciences;
Plant Breeding;
Human Genome Program;
Beijing Genomics Institute;
BGI;
Rice Genome;
Technological Innovation;
Innovation Strategy;
Research;
Research and Development;
Science;
Genetics;
Science-Based Business;
Strategy;
Commercialization;
Corporate Strategy;
Information Technology;
Applications and Software;
Agriculture and Agribusiness Industry;
Biotechnology Industry;
Food and Beverage Industry;
China;
United States
Shih, Willy, and Sen Chai. "BGI: Data-driven Research." Harvard Business School Case 614-056, February 2014.
- January 2014 (Revised December 2014)
- Case
GenapSys: Business Models for the Genome
By: Richard G. Hamermesh, Joseph B. Fuller and Matthew Preble
GenapSys, a California-based startup, was soon to release a new DNA sequencer that the company's founder, Hesaam Esfandyarpour, believed was truly revolutionary. The sequencer would be substantially less expensive—potentially costing just a few thousand dollars—and... View Details
Keywords:
DNA Sequencing;
Life Sciences;
Business Model;
Innovation & Entrepreneurship;
Health Care and Treatment;
Genetics;
Business Strategy;
Biotechnology Industry;
Pharmaceutical Industry;
Technology Industry;
Health Industry;
Medical Devices and Supplies Industry;
United States
Hamermesh, Richard G., Joseph B. Fuller, and Matthew Preble. "GenapSys: Business Models for the Genome." Harvard Business School Case 814-050, January 2014. (Revised December 2014.)
- August 2013
- Course Overview Note
Building Life Science Businesses Fall 2013: Course Outline and Syllabus
This Course Outline and Syllabus gives an overview of the Fall 2013 class Building Life Science Businesses.
View Details
Keywords:
Healthcare Ventures;
Entrepreneurial Management;
Entrepreneurship;
Entrepreneurs;
Health Care and Treatment;
Health Testing and Trials;
Medical Specialties;
Health Industry;
Biotechnology Industry;
Medical Devices and Supplies Industry;
Asia;
North America;
Europe
Hamermesh, Richard G. "Building Life Science Businesses Fall 2013: Course Outline and Syllabus." Harvard Business School Course Overview Note 814-019, August 2013.
- January 2013 (Revised September 2013)
- Case
Royal DSM: Fighting Hidden Hunger
By: Rebecca Henderson, Noah Fisher and Mary Shelman
In 2007 Royal DSM, a leading life science and materials company, entered a partnership with the World Food Programme (WFP) to combat hidden hunger around the world by providing micronutrient solutions. The case investigates the unexpectedly large impact the partnership...
View Details
Keywords:
Conflict of Interests;
Human Needs;
Partners and Partnerships;
Global Range;
Nutrition;
Science-Based Business;
Non-Governmental Organizations;
Service Industry;
Health Industry
Henderson, Rebecca, Noah Fisher, and Mary Shelman. "Royal DSM: Fighting Hidden Hunger." Harvard Business School Case 313-085, January 2013. (Revised September 2013.)